Early phase
The ability to enroll healthy participants quickly and efficiently in early phase studies is critical to developing new medicines and vaccines for the patients that need them. Identifying the appropriate participants, whether healthy volunteers or patients in “first in patient” studies, can often be a challenge, but a partner with four decades of early phase development experience has what it takes to enable you to advance your study with speed.
Why Trialmed for early phase clinical trials?
Our site-specific early development capabilities address all of your regulatory requirements for clinical conduct, including first-in-human, first-in-patient (proof of concept) and all other early-phase needs, including:
- Absorption, Distribution, Metabolism and Excretion (ADME)
- Bioavailabity
- Food effect
- Drug interaction
- Concentration QT studies
Our flagship site in Austin, Texas, is one of the largest and best-equipped early phase units globally, with decades of experience delivering high-quality data while maintaining a laser focus on participant safety and comfort.
Our early phase solutions work to reduce the cost and duration of your development timeline. Through our experience, we’re able to anticipate potential challenges, recruit the right participants—including healthy volunteers and special populations—and foster diversity in clinical trials. As your trial advances, you can count on a seamless transition to integrated robust late phase capabilities covering a wide range of indications, meaning if you start with us, you can stay with us.
Other key Trialmed differentiators include:
Dedicated sites
Both of our dedicated facilities with integrated capabilities in the U.S. offer niche know-how to address the most demanding clinical needs. Our sites operate under the same stringent standard operating procedures and all staff are comprehensively trained to ensure studies are conducted with the highest levels of quality, attention to detail, and overall excellence.
Industry relationships
Our industry relationships include strong affiliations with some of the world’s best independent early development clinics. When you have a specific need for a specific patient population or need to conduct studies outside of the U.S., we can immediately set you up for success. All affiliated sites have been vetted by our internal teams to earn our confidence.
Concierge approach
Our experience accessing rare disease and difficult-to-find patient populations is driven by our proactive concierge approach. We coordinate directly with clinicians to share information and recruit the right patients to your study.